Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Exon 51 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/08/599   
Active ingredient: Exon 51 specific phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: BioMarin International Limited
6th Floor, 2 Grand Canal Square, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Orphan Designation EMEA/OD/082/08 (2009)1525 of 27/02/2009
08/06/2010 Transfer of orphan designation EMEA/OD/082/08/T/01 (2010)3713 of 04/06/2010
04/02/2014 Change of address of sponsor
15/04/2014 Transfer of orphan designation EMEA/OD/082/08/T/02 (2014)2621 of 11/04/2014
28/04/2015 Transfer of orphan designation EMA/OD/082/08/T/03 (2015)2952 of 24/04/2015
08/06/2015 Change of address of sponsor